Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
The British Journal of Radiology|November 1, 1992
Stage IB cervical carcinoma: a clinical auditM N Gaze, C G Kelly, P R Dunlop, et al.Journal of Neurochemistry|July 17, 2021
Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistanceChangiz Geula, Sara R Dunlop, Ivan Ayala, et al.JAMA|June 20, 1998
Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via EpidemiologyR Bernabei, G Gambassi, K Lapane, et al.Radiology|June 1, 1988
Right ventricular tardokinesis in cardiac contusion: a new observation on phase imagesV W Lee, J C Allard, P Berger, et al.The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|December 2, 2011
Using foresight to prepare animal health today for tomorrow's challengesNorman G Willis, Fonda A Munroe, R Edward Empringham, et al.Cancer Research|May 9, 2018
Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with GemcitabineSiang-Boon Koh, Yann Wallez, Charles R Dunlop, et al.British Journal of Cancer|August 4, 2020
Complete loss of ATM function augments replication catastrophe induced by ATR inhibition and gemcitabine in pancreatic cancer modelsCharles R Dunlop, Yann Wallez, Timothy Isaac Johnson, et al.Science Signaling|May 7, 2020
p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulatorsCharles N Birts, Arindam Banerjee, Matthew Darley, et al.Ebiomedicine|May 28, 2021
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approachTimothy I Johnson, Christopher J Minteer, Daniel Kottmann, et al.Molecular Cancer Therapeutics|June 13, 2018
The ATR Inhibitor AZD6738 Synergizes with Gemcitabine <i>In Vitro</i> and <i>In Vivo</i> to Induce Pancreatic Ductal Adenocarcinoma RegressionYann Wallez, Charles R Dunlop, Timothy Isaac Johnson, et al.Pageof 6